Related Experiment Video

Updated: Aug 9, 2026

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis
08:42

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

Published on: April 10, 2019

Case report: Yersinia enterocolitica necrotizing pneumonia in an immunocompromised patient

J N Greene1, P Herndon, J P Nadler

  • 1Department of Medicine, University of South Florida College of Medicine, Tampa.

The American Journal of the Medical Sciences
|March 1, 1993
PubMed

Insights

A rare Yersinia enterocolitica necrotizing pneumonia case in an immunocompromised patient resolved with antibiotics. Early recognition and treatment of this infection in vulnerable populations are crucial for improving survival.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Yersinia enterocolitica is an uncommon cause of pneumonia, particularly in immunocompromised individuals.
  • Necrotizing pneumonia is a severe lung infection characterized by tissue death.
  • The increasing population of immunocompromised patients presents challenges in diagnosing and managing opportunistic infections.

Observation:

  • A rare case of Yersinia enterocolitica necrotizing pneumonia occurred in an immunocompromised patient.
  • The patient received a third-generation cephalosporin for 6 weeks, leading to infection resolution.
  • Despite successful infection treatment, the patient ultimately succumbed to their underlying lymphoma.

Findings:

  • Yersinia enterocolitica pulmonary infections, though rare, have an excellent prognosis with appropriate antibiotic therapy.
  • Appropriate antibiotic selection is critical for managing Yersinia enterocolitica pneumonia.
  • Early diagnosis and prompt treatment significantly improve survival rates for Yersinia enterocolitica pulmonary infections.

Implications:

  • Yersinia enterocolitica should be considered in the differential diagnosis of pneumonia in immunocompromised patients.
  • Increased recognition of Yersinia enterocolitica as a pathogen in immunosuppressed individuals is anticipated.
  • Timely and effective antimicrobial intervention can enhance patient outcomes in serious Yersinia enterocolitica infections.

More Related Videos

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

A Neonatal Mouse Model of Necrotizing Enterocolitis and Lamina Propria Isolation for Immune Cell Profiling09:13

A Neonatal Mouse Model of Necrotizing Enterocolitis and Lamina Propria Isolation for Immune Cell Profiling

Published on: September 19, 2025

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Cholera01:25

Cholera

Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...